Funding

• DFG-RTG2504 - “Novel antiviral approaches: from small molecules to immune intervention”
• MetrioPharm AG, Zurich, Switzerland
• ImmunoLogik GmbH, Berlin
• Marinomed AG, Korneuburg, Austria
• Iprona AG, Lana, Italy
• Kinarus AG, Basel, Switzerland
• Coronavirus Research Fund of the Bavarian State Ministry for Science and the Arts

Collaborations

• Dr. Ashok Balasubramanyam, Baylor College of Medicine, Houston, TX, USA
• Prof. Dr. Matthias Tenbusch, Institute of Virology, University of Erlangen-Nürnberg, Germany
• Dr. Petra Henklein, Humboldt University, Berlin, Germany
• Prof. Dr. Michael Schindler, Medizinische Virologie und Epidemiologie der Viruskrankheiten, Universitätsklinikum Tübingen, Germany
• Prof. Dr. Jan Münch, University of Ulm, Germany
• Prof. Dr. Armin Ensser, Institute of Virology, University of Erlangen-Nürnberg, Germany
• Prof. Dr. Claus Hellerbrand, Institute of Biochemistry, Friedrich-Alexander-Universität Erlangen-Nürnberg, Germany
• Prof. Dr. Alexander Steinkasserer, Department of Immune Modulation, Universitätsklinikum Erlangen, Germany